Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study

Jor, Ondřej; Máca, Jan; Koutná, Jiřina; Gemrotova, Michaela; Vymazal, Tomáš; Litschmannová, Martina; Ševčík, Pavel; Reimer, Petr; Mikulova, Vera; Trlicova, Michaela; Černý, V.

doi:10.1007/s00540-018-2532-6

Cited by 120 publications

(123 citation statements)

References 16 publications

Supporting

Mentioning

106

Contrasting

Unclassified

Order By: Relevance

“…Hypotension is frequently observed as a side effect during induction of anesthesia using propofol [20][21][22]. A phase I clinical trial for remimazolam revealed that a 1-min bolus infusion of remimazolam 0.01-0.30 mg/kg did not cause hypotension, which was defined as systolic blood pressure lower than 80 mmHg, except one occurrence of hypotension 8 h after the dose of remimazolam [2].…”

Section: Hypotension: Side Effect Of Induction Agentmentioning

confidence: 99%

Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!

Masui

2020

J Anesth

View full text Add to dashboard Cite

Section: Hypotension: Side Effect Of Induction Agentmentioning

confidence: 99%

Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!

Masui

2020

J Anesth

View full text Add to dashboard Cite

“…Hypertension is a common chronic condition in surgical patients requiring anesthesia [23][24][25]. ACE inhibitors and/ or angiotensin-receptor blockers (ARBs) are often used for perioperative blood pressure control in surgical patients with a history of hypertension and other cardiovascular diseases [23].…”

Section: Suggested Mechanism Of Covid-19mentioning

confidence: 99%

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Hirata

Yamakage

2020

J Anesth

View full text Add to dashboard Cite

The coronavirus disease (COVID-19) pandemic has brought critical challenges to anesthesiologists and perioperative practice. Whereas anesthesiologists may be primarily concerned with airway and respiratory management, the COVID-19 data accumulated to date indicate that primary and/or secondary cardiovascular complications are common. Previous studies have demonstrated that the mortality rate is significantly higher in patients with cardiovascular disease (CVD) than in patients without CVD. Dysregulation of immune function in patients with CVD may be involved in the prognosis of COVID-19 patients. Anesthesia and surgical procedures can modulate the immune system, and some patients undergoing surgery, particularly those undergoing cardiovascular procedures, have CVD. In perioperative management for patients with suspected or diagnosed COVID-19 and those who have recovered from COVID-19, it is important for anesthesiologists to be concerned not only with airway and respiratory management, but also with cardiovascular complications and perioperative circulatory management to control the progression of the disease in patients with COVID-19.

show abstract

“…Conventional surgical options such as bypass grafting or arterial transposition are related with much higher blood loss than endovascular procedures and more perioperative complications [7,26]. General anaesthesia is linked with perioperative blood pressure drop, which in patients with multiple aortic arch syndrome might additionally lower the cerebral perfusion [27]. Endovascular procedures do not require general anaesthesia, so its impact on blood pressure is reduced.…”

Section: Is Minimally Invasive Treatment Still Possible In Multiple Ementioning

confidence: 99%

Multiple occlusions in extracranial arteries in patients with aortic arch syndrome: is minimally invasive treatment still possible? Technical aspects of the treatment based on our own experience and a review of the literature.

Kaszczewski¹,

Ostrowski²,

Maciąg³

et al. 2020

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

Takayasu arteritis is a large vessel vasculitis of granulomatous nature and unknown aetiology affecting predominantly the aorta and its major branches, which may lead to ischaemic symptoms of many organs including the central nervous system. To decrease the risk of neurological complications and improve the quality of life, an arterial revascularisation may be necessary. The treatment options include pharmacotherapy as well as both open surgical and endovascular procedures, which has to be carefully chosen to obtain clinical success. There is an ongoing debate on the advantages, possibilities, and indications for implementing endovascular and open surgical methods, especially in high-risk patients. In this article we present our own experience in the treatment of an unusually complex and high-risk patient with multiple occlusion of supra-aortic branches, focusing on the technical aspects of the procedures and the decision-making process, as well as to confront with contemporary medical knowledge.

show abstract

Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study

Abstract: GAIH rate depends on age, degree of blood pressure decompensation prior the surgery, and presence of diabetes mellitus type II.

Cited by 120 publications

References 16 publications

Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!

Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Multiple occlusions in extracranial arteries in patients with aortic arch syndrome: is minimally invasive treatment still possible? Technical aspects of the treatment based on our own experience and a review of the literature.

Contact Info

Product

Resources

About